USC Norris Comprehensive Cancer Center
External Advisory Board
The External Advisory Board (EAB) serves a critical role in helping USC Norris regularly evaluate its progress and achieve continuous improvement. EAB members include prominent investigators from other cancer centers who represent diverse research disciplines, Center Directors, and administrative leaders. The EAB meets annually to assess USC Norris’s strategic priorities, scientific initiatives, organization and leadership, and progress in its programs, shared resources, community outreach and engagement, education and training, administration, and developmental funds. The EAB prepares a written report, subsequently reviewed and acted upon by USC Norris leadership with progress updates at subsequent meetings.
The Maurice and Marguerite Liberman
Distinguished Chair in Cancer Research
Professor, Department of Internal Medicine
Director & CEO, University of New Mexico
Comprehensive Cancer Center
Chair and Professor, Epidemiology and
Population Health; Stanford Medicine Discovery
Professor; Associate Director, Population
Sciences | Stanford Cancer Institute; Co-Director,
Center for Population Health Sciences
Professor of Medicine; Division of
Hematology/Oncology, Associate Director for
Community Outreach and Engagement;
Associate Director for Health Equity, UPMC
Hillman Cancer Center; Assistant Vice Chancellor
for Community Health Equity; Office of the
Senior Vice Chancellor for the Health Sciences;
The University of Pittsburgh
Associate Director for Diversity, Equity, and Inclusion; Vice President, Faculty Affairs and Diversity; Helen G. Edson Endowed Chair for Breast Cancer Research; Professor, Translational Research Program and Epidemiology Program Research Full Professor, Department of Epidemiology; Fred Hutchinson/University of Washington Cancer/Seattle Children’s Consortium
Professor, Department of Medicine –
Section of Hematology/Oncology
Chair, Committee on Clinical Pharmacology and Pharmacogenomics
Associate Director for Education, UCCCC
University of Chicago
Professor, Department of Medicine; Amy Davis
chair, Basic Immunology Research; Director,
Immunotherapy Medical Oncology; Associate
Director, Cancer Research Training and
Education; University of Colorado
Comprehensive Cancer Center
Professor, Department of Public Health Sciences
Associate Director, Office of Community
Outreach and Engagement; Director, Women
Cancers Care and Research Program (WeCARE)
University of California Davis Comprehensive
Cancer Center; University of California Davis
School of Medicine
Professor, Ben May Department for Cancer
Research & Department of Pathology
University of Chicago
Chief Scientific Officer
Van Andel Institute
Executive Director, Duke Cancer Institute
William and Jane Shingleton Professor, Pharmacology and Cancer Biology
Professor of Pediatrics, Duke University School of Medicine
Amy and Joseph Perella Professor of Medicine
(Medical Oncology), Associate Center Director of
Experimental Therapeutics, Director of Early
Therapeutics Disease-Aligned Research Teams
Yale Cancer Center, Yale University
Chief Administrative Officer
UCLA Jonsson Comprehensive Cancer Center
Harry P. Schenck Professor in Otorhinolaryngology
University of Pennsylvania
Perelman School of Medicine